Advancing 21st Century Pain Management Conference (August 17, 2018)

  • CMPI | by: CMPI |
  • 07/24/2018 12:00 AM
N/A by N/A is licensed under N/A N/A
Advancing 21st Century Pain Management 
 
 
The Current State of Abuse Deterrent Technology Development and Adoption
 
Challenges and Opportunities
 
Co-sponsored by the Innovative Pain Medicines Alliance and the Abuse Deterrent Coalition
 
Featuring FDA Commissioner Scott Gottlieb, M.D. 
 
 
Join the Center for Medicine in the Public Interest on Friday, August 17 at the National Press Club to explore risks and opportunities related to policy for a discussion of abuse deterrent technologies and their place in the 21st Century Pain Management Arsenal. 
 
Our program will feature a slate of expert panels, as well as a keynote address from Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D. 
 
This invitation is non-transferable. 
Room size is limited: Each organization may provide up to two attendees.
Kindly RSVP by August 3.
 
 
When: Friday, August 17
8:00 - 11:30 am ET
Breakfast will be served
 
 
Where: The Holeman Lounge
National Press Club 
529 14th Street, NW, 13th Floor 
Washington D.C. 20045
 
To RSVP: mcoluccio@cmpi.org
If you would like to attend, please contact Mario Coluccio to check on availability. Space is limited.
 
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

FDA  Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15
  • NEWSY
  • 01/04/2022 12:00 AM

FDA Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15

CMPI's Peter Pitts discusses FDA approval of Pfizer COVID vaccine booster for children ages 12-15...  Read more

Should We Rethink The FDA Commissionership?

Should We Rethink The FDA Commissionership?

When one considers the FDA’s mission—to independently protect consumers and advance the public health—it is not at all cl...  Read more

DRUGWONKS BLOG